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Abstract.  Botulinum C3 exoenzyme specifically ADP- 
ribosylates a group of ms-related small molecular 
weight GTP-binding proteins,  rho, and inhibits their 
biological activity.  Using this enzyme, we examined 
the function of rho in PMA-induced activation of lym- 
phocyte function-associated antigen-1  (LFA-1) in a B 
lymphoblastoid cell line, JY.  Northern blot analysis 
revealed that among the three rho genes,  rhoA  mRNA 
was predominantly expressed in JY cells.  Consistently, 
only one [32p]ADP-ribosylated band was found when 
the lysate of the cells was subjected to ADP ribosyla- 
tion by C3 exoenzyme. When the cells were cultured 
with C3 exoenzyme, this substrate was ADP- 
ribosylated in situ in a time- and concentration- 
dependent manner.  Concomitant with this ADP 
ribosylation, PMA-induced LFA-1/intercellular adhe- 
sion molecule (ICAM)-l-dependent aggregation of JY 
cells was inhibited.  This inhibition was blocked by 
prior treatment of the enzyme with an anti-C3 mono- 
clonal antibody, and overcome by stimulation with 
higher concentrations of PMA. The C3 exoenzyme- 
induced inhibition  was not affected by shaking of the 
cell suspension, while inhibition of aggregation by 
cytochalasin B was abolished by this procedure,  sug- 
gesting that the inhibitory effect of the C3 exoenzyme 
treatment was not due to decrease in cell motility. The 
C3 exoenzyme treatment affected neither protein phos- 
phorylation in JY cells before and after PMA stimula- 
tion,  nor affected surface expression of LFA-1 and 
ICAM-1.  These results suggest that rhoA protein works 
downstream of protein kinase C activation linking 
PMA stimulation to LFA-1 activation and aggregation 
in JY cells. 
R 
as and ras-related  genes constitute a gene family en- 
coding a series of closely related proteins with gua- 
nine nucleotide-binding activities.  To date, ~40 ras 
and ras-related GTP-binding  proteins are known,  and they 
are divided into four subfamilies:  ms, rho, tab, and others 
(Hall, 1990; Bourne et al., 1991). These proteins exist in two 
interconvertible  functional  states; one in an inactive GDP- 
bound form and the other in an active GTP-bound form. In 
resting  cells,  they  are present in  an  inactive  GDP-bound 
form,  and  upon  cell  stimulation,  converted  to the active 
GTP-bound form and work as molecular switches linking ex- 
ternal stimuli to various cellular responses such as growth, 
differentiation,  and secretion. Among the ras-related  GTP- 
binding proteins,  rho proteins are believed to be involved in 
organization  of cytoskeleton and maintenance  of cell shape. 
There are at least three members in this  family in human, 
which are called rhoA,  B,  and  C (Yeramian et al.,  1987; 
Chardin et al.,  1988).  rho proteins are unique among  the 
small  GTP-binding  proteins  in  being  substrates  for ADP 
ribosylation by the exoenzyme C3 from Clostridium botuli- 
num (Aktories et al.,  1987; Morii et al.,  1988; Narumiya 
et  al.,  1988;  Kikuchi  et al.,  1988).  This  enzyme ADP- 
ribosylates the proteins at an asparagine  residue in the puta- 
tive effector domain and inhibits  their biological activities 
presumably by interfering  with their  interaction  with the 
putative downstream effector molecules (Sekine et al., 1989; 
Morii et al., 1991). ADP ribosylation  of the rho proteins by 
C3 exoenzyme and their activation by GTP result in opposite 
phenotypes in cultured cells. A typical change induced by the 
ADP ribosylation is rounding-up of cell bodies associated with 
disassembly of aetin filaments (Rubin et al.,  1988; Chardin 
et al., 1989; Paterson et al., 1990), whereas microinjection 
of the activated  rhoA  mutant  protein  into  fibroblasts  en- 
hances actin filament organization and induces fingerlike cell 
processes (Paterson et al., 1990). These results suggest that 
rho proteins are involved in the organization of actin filament 
and the formation  of adhesion plaques, and that  the ADP 
ribosylation  abolishes their activities.  However, it remains 
unclear how and under what physiological conditions the rho 
protein exerts such action. 
The integrin  family of adhesion  molecules plays a major 
role in the formation  of adhesion plaques and also mediates 
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associated antigen-1  (LFA-1)  ~ is a member of the leukocyte 
integrins, and suggested to be involved in such processes as 
target cell recognition by cytolytic T lymphocytes and natu- 
ral killer cells, binding of T lymphocytes to antigen presen- 
tation cells, and leukocyte adhesion to endothelial cells, fibro- 
blasts,  and epithelial cells  (Springer,  1990).  The counter- 
receptors  for  LFA-I  are  intercellular  adhesion  molecules 
(ICAMs)-I and -2. LFA-1 is not constitutively avid for ICAMs 
but interaction with the ICAMs requires activation  of LFA-1 
(Dustin and Springer,  1989;  van Kooyk et al.,  1989).  This 
activation  event can be triggered by stimulation of T cell re- 
ceptor or CD2 on T lymphocytes or by the addition of phor- 
bol esters (Rothlein and Springer,  1986;  van Kooyk et al., 
1989). However, the signal transduction  pathway from these 
stimuli to the activation  of LFA-1 remains unclarified. In this 
study, we examined the possible role of the rho protein in sig- 
nal transduction  in stimulus-evoked LFA-1 activation and cell 
aggregation.  We chose JY Epstein-Barr  virus-transformed 
B lymphoblastoid cells (Rothlein and Springer,  1986),  and 
examined the effects of ADP ribosylation of rho protein by 
C3 exoenzyme on the PMA-induced aggregation  of JY cells. 
Materials and Methods 
Materials 
Recombinant botulinum  C3  exoenzyme was prepared  essentially as de- 
scribed (Nemoto et al., 1991). Mouse IgG1 monoclonal anti-C3 exoenzyme 
antibody,  C302-1, was prepared  as described  previously  (Morii  et al., 
1990). [c~-32p]NAD  + (800 Ci/mmol) was obtained from Du Pont-New En- 
gland Nuclear (Boston, MA). PMA was obtained from Sigma Chem. Co. 
(St. Louis, MO), and mouse IgG was from ICN Biomedicals, Inc. (Costa 
Mesa, CA). Human rhoA cDNA was isolated from human placenta cDNA 
library  by cross hybridization with bovine rhoA clone (Ogorochi et al., 
1989). Human rhoB and rhoC cDNA are girls from A. Tavitian (Institut 
National de la Sante et de la Recherche Medicale, Pads, France) and K. 
Shinjo (Kanegafuchi Chemical Industry Co., Osaka, Japan), respectively. 
Cell Line 
An Epstein-Barr  virus-transformad  B  lymphoblastoid  cell  line JY  was 
generously  provided  by  Drs.  K.  Okumura  and  H.  Yagita of Juntendo 
University School of Medicine (Tokyo, Japan), and maintained in RPMI 
1640 medium supplemented with  10% FCS. 
Northern Blot Analysis 
RNA  was  extracted  from  JY  cells  using  the  guanidine  thiocyanate 
homogenization procedure  and polyadenylated,  or poly(A)  +,  RNA  was 
prepared  by  olig~dT)  cellulose  column  (Pharmacia  LKB, Uppsala, 
Sweden). RNA (5 ~tg) were separated on a  1% agarose-formaldehyde gel 
and  were  transferred  to  a  Hybond-N  +  membrane  (Amersham  Corp., 
Arlington Heights, IL). A SaclI-VspI fragment (900 bp) from rhoA cDNA, 
a PstI-SmaI fragment (550 bp) from rhoB cDNA, and a BalI-PstI fragment 
(321 bp) from rhoC cDNA were radiolabeled by random-priming and used 
as probes.  They contain  fragments of the Ynoncoding regions and the 
Yend of  the coding regions. Probes used detected their own cDNA but did 
not crosshybridize with the others.  Filters were hybridized overnight at 
56~  in 5x SSC-0.5%  SDS-5x Denbardt's solution-100 #g/ml of dena- 
tured salmon sperm DNA. Filters were washed with Ix SSC-0.1% SDS at 
60~  and then with 0.2￿  SSC-0.1% SDS at 60~  and exposed to an x-ray 
film at  -70~  for 56 h with an intensifying screen. 
1. Abbreviations used in this  paper: ICAM, intercellular adhesion molecule; 
LFA-1, lymphocyte function-associated  antigen-1. 
C3 Exoenzyme Pretreatment, Cytochalasin B 
Treatment, and Aggregation Assay of  JY Cells 
Logarithmically growing JY cells were taken and plated at 7.5  x  105/well 
in 1.5 ml of  the complete medium in a 6-well plate and cultured with various 
concentrations of C3 exoenzyme for indicated periods. Treatment with C3 
exoenzyme affected neither cell viability nor cell size. The cells were then 
washed twice with RPMI  1640, and suspended at a density of 2  x  106 
cells/ml in RPMI  1640 containing 5 mM Hepes-NaOH,  pH 7.4 (Sigma 
Chem. Co.).  100 #1 of the cell suspension was added to a well of 96-well 
plate. PMA was then added, and the final volume of  the suspension was ad- 
justed to 200 #l/well. They were placed in a CO2 incubator and aggrega- 
tions of the cells were observed at 30 min, 3 h, and 16 h after the PMA 
addition. Aggregation was also quantified according to the method of Roth- 
lein and Springer (1986). Briefly, cells were added to polystyrene tubes at 
4  x  105 cells in 200 #1. One group of control cells received cytochalasin 
B at 2 #M. PMA was added and tubes were shaken at 200 rpm in a CO2 
incubator for 2 h. The sample was subjected to analysis on a Coulter Mul- 
tisizer counter (Coulter Scientific Instruments, Hialeah, FL), and free cells 
in the suspension were measured.  The percentage of aggregation of cells 
was calculated using the formula: 100 x  [1 -  (number of  free cells/number 
of input cells)]. 
Effects of cytochalasin B on JY cell aggregation was further examined 
by pretreating the cells with 2 ~M cytochalasin B for 5, 30, and 60 min be- 
fore PMA addition and by incubating them with various concentrations 
(0.2, 0.7, 2, 7, and 20 ~tM) of this compound with PMA. Aggregation was 
determined at 2 h after the PMA addition by the quantitative method as de- 
scribed above. 
ADP Ribosylation 
Aliquots of  cells were taken after the C3 exoenzyme treatment, washed, and 
spun down by brief centrifugation. Cell pellets were suspended in 50 #1 of 
0.25 M sucrose containing 20 mM Tris-HC1, pH 7.5, 5 mM MgC12, 1 mM 
EDTA, 1 mM DTT, 2 mM bepTamidine hydrochloride, and 0.5 mM PMSE 
The suspension was homogenized by sonication and the homogenate was 
centrifuged at 1,000 g for 5 rain.  Supernatants (50 #g protein) were in- 
cubated at 30~  for 1 h with 50 ng C3 exoenzyme and 10 #M [32p]NAD  + 
(specific radioactivity, 2,000 cpm/pmol) in 100 mM Tris-HC1, pH 8.0, con- 
taining 20 mM nicotinamide, 10 mM thymidine, 10 mM DTT, and 5 mM 
MgC12 in a total  volume of 100 #1.  APter the reaction,  the mixture was 
subjected to SDS-PAGE and the ADP ribosylation was determined as de- 
scribed previously (Morii et al.,  1990). 
Analysis of  Protein Phosphorylation by 
Two-Dimensional Polyacrylamide Gel Electrophoresis 
4  x  106 cells, pretreated  with or without C3 exoenzyme, were washed 
twice with the RPMI medium and then twice with phosphate-free medium 
(30 mM Hepes-NaOH, pH 7.4, 110 mM NaCI, 11 mM glucose, 5 mM KCI, 
1 mM CaCI2, 1 mM MgC12, 2 mg/ml BSA), and incubated for 120 rain in 
50  ~1  of the phosphate-free  medium  supplemented  with  0.15 mCi  of 
[32p]orthophosphate (Du Pont-New England Nuclear) in a CO2 incubator 
at 37~  Labeled cells were then stimulated with 50 ng/mi of PMA for 20 
min, chilled, and collected by centrifugation. Cell pellets were lysed with 
500/~1 of the solubilizing buffer containing 10 mM Tris-HC1, pH 7.4, 1% 
NP-40, 66 mM EDTA, 0.4% sodium deoxycholate, 1% aprotinin,  1 mM 
PMSF, 1 mM sodium orthovanadate, and 0.05% sodium azide. After cen- 
trifugation at 10,000 g for 10 rain, 2.5-#1 aiiquots were taken from superna- 
tants to determine TCA-insoluble radioactivity, and the same volume of  ali- 
quots were used for the two-dimensional PAGE analysis. The samples were 
first subjected to NEPHGE (pH 3.5-10) (O'Farrell et ai., 1977) at 400 V 
for 4  h, and then to SDS-PAGE on a 10% gel (Laemmli,  1970). After the 
electrophoresis, the gel was dried and the electrophoretic patterns of radio- 
labeled polypeptides were analyzed by the use of a Fuji BAS 2000 image 
analyzer (Fuji Film Co., Tokyo, Japan). 
Flow Cytometry 
Cells cultured with C3 exoenzyme for 24 h were washed with the RPMI 
medium twice and collected by centrifngation.  105 cells were incubated 
with  20  #g  of mouse  monoclonal  anti-LFA-lc~ antibody  (G-25.2) or 
anti-ICAM-1 antibody (LB-2) for 1 h at 4~  The cells were then washed 
twice with 1 ml of  ice-cold HBSS containing 0.75 % BSA and 0.05 % sodium 
azide  (Hanks'-BSA),  and  incubated  with  10  ttg  of  FITC-conjngated 
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30 rain  on ice. The cells  were  washed  again three  times  with I ml of  Hanks'- 
BSA, suspended  in 1 ml of  the same  solution,  and subjected  to the analysis 
on a Cytoron flow cytometer  (Ortho Diagnostic Systems Co., Tokyo, 
Japan). 
Results 
Expression and ADP Ribosylation ofrho Proteins in 
JY Cells 
There are three rho genes in human: rhoA, B, and C. Using 
Northern blot analysis, we examined which rho gene was ex- 
pressed in cultured JY cells. As shown in Fig. 1 A, rhoA was 
highly expressed in JY cells, whereas expression of rhoB and 
rhoC was observed at very low levels, rhoA mRNA was pres- 
ent as  a  doublet as  reported previously (Olofsson et al., 
1988;  J~ihner  and  Hunter,  1991).  Consistent  with  these 
findings, only one [32p]ADP-ribosylated band was observed 
when lysates of  the cells were ADP-ribosylated by C3 exoen- 
zyme and subjected to SDS-PAGE (Fig.  1 B). 
We incubated the JY cells with various concentrations of 
C3 exoenzyme for various lengths of time. After incubation, 
we washed cells, homogenized and subjected the homoge- 
hate to ADP ribosylation to determine the amount of the 
ADP ribosylation substrate remaining in the cells.  Fig.  2 
shows typical autoradiograms of  these analyses. The amount 
of the ADP ribosylation substrate in cells treated with 20 
/~g/ml of C3 exoenzyme  decreased significantly with incuba- 
tion time (Fig. 2 A). Observed decreases were 52.2, 67.1, and 
77.8%  with 8-,  16-,  and 24-h incubation,  respectively. As 
Figure 2.  Time- and concentration-dependent decrease  in ADP 
ribosylation substrate  in C3  exoenzyme-treated cells.  (A) TLme 
course.  Cells were cultured with (lanes 2, 4, and 6) or without 
(lanes 1, 3, and 5) 20 ~g/ml of C3 exoenzyme for 8 (lanes 1 and 
2), 16 (lanes 3 and 4), and 24 h (lanes 5 and 6). Cells were homoge- 
nized and centrifuged at 1,000 g. The remaining ADP ribosylation 
substrate  (unmodified  rhoA protein)  in  the  cells  was  ADP- 
ribosylated in vitro with C3 exoenzyme and [32p]NAD+, and ana- 
lyzed by SDS-PAGE  and autoradiography as described in Materials 
and Methods. (B) Concentration dependency. Cells were treated 
with 0 (lane 1), 3 0ane 2), 10 (lane 3), and 30 (lane 4) pg/ml of 
C3 exoenzyme for 24 h. The remaining ADP ribosylation substrate 
in the cells was analyzed as described above. 
Figure L Northern blot analysis of rhoA, B, and C mRNA expres- 
sion in cultured JY cells (,4) and [32p]ADP  ribosylation of rho pro- 
teins (B). (,4) Poly(A)  + RNA (5 ~g/lane) from JY cells was sepa- 
rated in a  1%  formaldehyde-agarose gel. The Northern blot was 
hybridized with 32p-labeled  eDNA probes of rhoA (lane 1), rhoB 
(lane 2), and rhoC  Oane 3) as described in Materials and Methods. 
Arrowheads indicate specific bands hybridized with each probe. 
(B) Postnuclear homogenate of  cells (50/~g) was subjected to ADP 
ribosylation by C3 exoenzyme in the presence of [32p]NAD+. Au- 
toradiogram of  SDS-PAGE  of  the sample is shown. Only the radio- 
active band at the 22 K was due to the catalysis of C3 exoenzyme, 
and other radioactive bands were also seen without the enzyme. 
shown in Fig. 2 B, the decrease in the amount of the ADP 
ribosylation substrate occurred in a manner dependent on the 
concentration of C3 exoenzyme used in the treatment. The 
decrease was 61.0, 78.1, and 83.2% in cells treated with 3, 
10, and 30 #g/ml of C3 exoenzyme for 24 h, respectively. 
These results suggest that the majority of rhoA protein in the 
cells had undergone ADP ribosylation in situ during the C3 
exoenzyme  treatment and became unable to be modified fur- 
ther with p2p]NAD  +. 
Inhibition by C3 Exoenzyme Treatment of 
PMA-Induced Aggregation of  JY Cells 
As previously reported by Rothlein and Springer (1986), JY 
cells aggregated in response to PMA and this aggregation 
was inhibited by anti-LFA-1 or anti-ICAM4 antibody (data 
not  shown).  This PMA-induced  cell aggregation was  in- 
hibited by the prior treatment of the cells with C3 exoen- 
zyme, and this occurred in a manner dependent on the treat- 
ment  time  and  the  enzyme  concentration  used  in  the 
treatment. As shown in Fig. 3 A, aggregation of control cells 
was observed from a 30-min incubation with PMA and the 
aggregates  became  larger  and  more  compact  thereafter. 
There were very few cells remaining free (panel a).  Cells 
pretreated with C3 exoenzyme for 8 h made loose aggregates 
and significant number of cells remained free (panel b). In 
cells with longer C3 exoenzyme treatment, PMA induced 
only small aggregates and the increasing number of cells 
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induced  aggregation  of  JY 
cells by C3 exoenzyme treat- 
merit.  (,4) Time dependency. 
Cells  were  treated  with  20 
#g/ml of C3 exoenzyme for 0 
(a),  8 (b),  16 (c),  and 24 (d) 
h. Cell aggregation  was then 
induced by 5 ng/ml of PMA as 
described  in  Materials  and 
Methods.  (B)  Concentration 
dependency. Cells were treated 
without (a and d) or with 10 
(b) or 30 (c) #g/ml of C3 exo- 
enzyme for 24 h. Aggregation 
was  induced  by  5  ng/ml  of 
PMA (a-c). Control cells with- 
out  PMA  were  shown  in d. 
Photographs were taken 16 (A) 
or 3 h (B) after the addition of 
PMA. The effect of C3 exoen- 
zyme treatment  was observed 
at 30 min, 3 h, and 16 h after 
the addition  of PMA and the 
inhibition  was found at any of 
the  three  observation  points. 
Bar,  100 t~m. 
were present either free or as clusters of a few cells (panels 
c and d). Fig. 3 B shows dependency of the inhibition on the 
enzyme concentration. In cells treated with 10 #g/ml of the 
enzyme for 24 h, aggregates were loose and many cells re- 
mained free (panel b). In ceUs treated with 30 #g/ml of the 
enzyme, aggregation was not observed clearly and their ap- 
pearance  was  similar  to  that  of the  control  cells  without 
PMA stimulation (panels c and d). Thus, the time course and 
dose dependency of C3 exoenzyme-induced inhibition cor- 
related  well  with  the  finding  on the  ADP ribosylation  in 
Fig.  2. 
To confirm that this inhibition is due to C3 exoenzyme it- 
self and not to any contaminants in the preparation,  we in- 
cubated the enzyme with anti-C3  exoenzyme mAb at 4~ 
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hibitory  activity  of C3  exo- 
enzyme by monoclonal anti- 
C3 exoenzyme  antibody. 20 #g 
C3 exoenzyme was incubated 
overnight at 4~  with or with- 
out 600 ~g of mouse mono- 
clonal anti-C3 exoenzyme an- 
tibody  in  500  #1  of  PBS. 
These  mixtures  were  then 
added  to  JY  cells,  and  the 
ceils were incubated for 24 h. 
The  cells  were  washed and 
aggregation  was evoked with 5 
ng/ml of PMA.  (a)  Control 
cells  without  PMA  stimula- 
tion;  (b) control cells stimu- 
lated with PMA for 30 min; 
(c)  cells  pretreated  with  C3 
exoenzyme  and  stimulated 
with PMA for 30 min; and (d) 
cells pretreated with a mixture 
of  C3 exoenzyme and anti-C3 
mAb and stimulated  with PMA 
for 30 min. Bar, 100 van. 
overnight, and added the mixture to JY cells.  After 24 h, 
aggregation was evoked by PMA  in the washed cells.  As 
shown in Fig. 4, pretreatment with anti-C3 exoenzyme  mAb 
abolished the inhibition of aggregation by C3 exoenzyme. 
Treatment of C3 exoenzyme  with normal mouse IgG did not 
affect  the  inhibitory  effect of C3  exoenzyme on  PMA- 
induced cell aggregation (data not shown). 
In the studies shown in Figs. 3 and 4, the inhibitory effect 
of C3 exoenzyme  pretreatment was examined in JY ceils set- 
fled on culture dishes. In this assay the cells locomote on a 
dish to contact each other to aggregate. This assay, therefore, 
may not distinguish inhibition of cell adhesion from impair- 
ment of cell motility. To clarify whether the inhibitory effect 
of C3 exoenzyme was due to the decrease in cell adhesion 
or to that in cell motility, we shook the cells in tubes and ex- 
amined the effect of C3 exoenzyme. We also compared it 
with that of cytochalasin B because this drug disrupts actin 
filament to inhibit various functions of it including cell mo- 
tility (Yahara et al.,  1982). A previous study (Rothlein and 
Springer, 1986) showed that this compound inhibited PMA- 
induced aggregation of JY cells on a culture dish. Cells were 
treated with 20 #g/ml C3 exoenzyme for 24 h, and subjected 
to the experiment. As shown in Table I, the control cells 
without the enzyme treatment aggregated by more than 60%. 
In contrast, only 27% of total cells aggregated after the C3 
exoenzyme treatment.  Cytochalasin  B  (2  #M)  was  then 
added to the control cells and its effect on aggregation was 
examined. Although this concentration of the drug inhibited 
aggregation completely in  experiments in  a  96-well plate 
(data  not  shown),  it showed no inhibition of aggregation 
when the cell suspension was shaken in a tube, and •80% 
of the cells aggregated. These results suggest that C3 exo- 
enzyme-induced inhibition is not secondary to impairment 
of cell motility but due to the inhibition of the induction of 
adhesive property of the cells.  These results also revealed 
that inhibition of cell aggregation with cytochalasin B re- 
ported in earlier studies is due to the inhibition of cell motil- 
ity and not to that of cell adhesion per se. 
Effects of cytochalasin B on JY cell aggregation were also 
examined by changing its concentration and the treatment 
time. When the cells were treated with 0, 0.2, 0.7, 2, 7, and 
20 #M cytochalasin B, aggregation induced by PMA was 55, 
58, 62,  70,  57,  and 40%,  respectively. When 2  #M cyto- 
chalasin B was added to the cells at 5 and 30 min, and 1 h 
before the addition of PMA,  79, 71,  and 60% aggregation 
was observed, respectively (control value  =  55%).  Thus, 
Table L Comparison of  the Effect of C3 Exoenzyme and 
Cytochalasin B on PMA-induced  Aggregation of  JY Cells 
under the Shaking Conditions 
Cells  % Aggregation* 
Control cells  62.7  +  3.9 
C3-treated cells  27.3 + 3.4w 
Cytochalasin B-treated cells  79.3 + 2.1' 
JY cells were treated with or without 20 ~tg/m] of C3 exoenzyme for 24 h. 
Cytochalasin B (2 t~M) was added to one group of control cells 5 min before 
the addition of PMA. Cell aggregation  was evoked and calculated as described 
under Materials and Methods. 
* Values are mean 5=  SEM of three different  experiments. 
*p <  0.05. 
w  p  <  0.01 for control cells. 
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PAGE  analysis  of  protein phos- 
phorylation in control and C3 
exoenzyme-treated  JY  cells. 
JY ceils preincubated with or 
without C3 exoenzyme were 
labeled  with  [32p]orthophos- 
phate. The  control and C3 exo- 
enzyme-treated cells were in- 
cubated  with  or  without  50 
ng/ml of PMA for 20 min and 
lysed as described in Materials 
and Methods. Each cell lysate 
(the NP-40-soluble fractions) 
was  subjected to an analysis 
on a two-dimensional  gel elec- 
trophoresis. (,4) Control cells 
without  PMA;  (B)  control 
cells with PMA; (C) C3 exo- 
enzyme-treated  cells without 
PMA; and (D) C3 exoenzyme- 
treated cells with PMA, Open 
arrowheads in B and D indi- 
cate proteins further phosphor- 
ylated after PMA stimulation. 
cytochalasin B up to 7 #M concentration or added at 2 #M 
at 1 h before PMA addition did not inhibit the JY cell aggre- 
gation, whereas it was partially inhibited with 20 #M con- 
centration of the compound. 
Effects of C3 Exoenzyme Treatment on 
Protein Phosphorylation  and Expression of 
LFA-1 and ICAM-1 in JY Cells 
It was recently reported that PMA-induced aggregation of  JY 
cells was blocked by protein kinase C inhibitors (Haverstick 
et al.,  1992), suggesting that protein kinase C is implicated 
in activation of the LFA-1/ICAM-l-mediated cell adhesion. 
We examined, therefore, whether the pattern of  protein phos- 
phorylation was affected by the treatment with C3 exoen- 
zyme. Cells were labeled with p2p]orthophosphate, incubated 
with or without PMA for 20 min, and lysed. Radioactivities 
in TCA precipitates of 2.5-~1  aliquots of the lysates were 
12,339,  12,956,  14,553, and  13,678  cpm for control cells 
without and  with PMA,  and  C3  exoenzyme-treated cells 
without and with PMA,  respectively. Thus,  there was no 
significant difference in incorporation of the radioactivity 
between the control and C3 exoenzyme-treated cells, indi- 
cating that the cells treated with C3 exoenzyme were meta- 
bolically intact. Fig. 5, A-D, presents the results of the gel 
electrophoresis of  the NP-40-soluble cell lysates. Phosphor- 
ylation of a number of  proteins was already observed in con- 
trol cells without the PMA stimulation (Fig. 5 A). After the 
PMA stimulation, several proteins were further phosphor- 
ylated and some proteins were newly phosphorylated (Fig. 
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Figure 6. Effect of C3 exoenzyme treatment on expression of LFA-1 
and ICAM-1 on JY cells. JY cells were incubated with or without 
50 #g/ml of C3 exoenzyme for 24 h.  The cells were then stained 
with  anti-LFA-la mAb or  anti-ICAM-1  mAb and  with  FITC- 
conjugated goat anti-mouse IgG, and subjected to a flow cytometric 
analysis as described in Materials and Methods. (a) LFA-1 expres- 
sion  on control  cells;  (b)  LFA-1 expression  on C3  exoenzyme- 
treated  cells;  (c)  ICAM-1 expression  on control  cells;  and  (d) 
ICAM-1 expression on C3 exoenzyme-treated  cells. 
5 B). In the C3-treated ceils, the phosphorylation pattern at 
resting was not different from the control cells (Fig. 5  C), 
and the proteins further phosphorylated by PMA were iden- 
tical to those seen in the control cells (Fig. 5 D). There was 
no difference, either,  in the phosphorylation pattern of the 
NP-40-insoluble residues between the control and C3 exo- 
enzyme-treated cells with or without PMA stimulation (data 
not shown). 
We next examined the expressions of LFA-1 and ICAM-1 
on JY cells. Immunofluorescence flow cytometry showed no 
change in LFA-1 (Fig. 6, A and B) or ICAM-1 (Fig. 6, C and 
D)  expression on JY cells by the  treatment with  C3  exo- 
enzyme. 
Antagonism of C3 Exoenzyme-induced 
Inhibition of  Aggregation by Stimulation with 
Higher Concentrations of  PMA 
The above results suggest that ADP ribosylation by C3 exo- 
enzyme is responsible for the inhibition of aggregation and 
the degree of inhibition depends on the extents of the ADP 
ribosylation in JY cells.  In such ADP ribosylation experi- 
ments, function of rho protein is presumed to depend on the 
balance of the stimulus-induced active GTP-bound form and 
the inactive ADP-ribosylated form which is supposed to be 
dominant negative. As shown in Fig. 2 B, ~20% of the rhoA 
protein in the cell was not ADP-ribosylated and remained in- 
tact even after the treatment with 30 #g/mi of the enzyme for 
24 h. In the case of ras p21, the percentage of the GTP-bound 
active form increased by stimulation with higher concentra- 
tions of phorbol ester (Downward et al.,  1990).  We, there- 
fore, examined whether the higher concentrations of PMA 
could overcome the inhibitory effect of C3 exoenzyme. After 
the treatment with 20 #g/ml of C3 exoenzyme for 24 h, the 
cells were stimulated by 0.5-500 ng/mi of PMA (Fig. 7). In 
control cells, aggregation was induced by the addition of 0.5 
ng/mi of PMA and aggregates became more compact with 
the addition of 50 and 500 ng/ml of PMA. In the C3 exoen- 
zyme-treated cells, aggregation was not induced by the addi- 
tion of 0.5 and 5 ng/mi of PMA.  However with 50 ng/mi of 
PMA, irregular and loose aggregates were induced and with 
500 ng/mi of PMA,  the aggregate formation became more 
apparent.  Thus,  the  C3  exoenzyme-induced inhibition  of 
aggregation was antagonized by stimulation with higher con- 
centrations of PMA. 
Figure 7. Antagonism of C3 exoenzyme-induced  inhibition of aggregation by higher concentrations  of PMA. JY cells were treated with 
(e-h) or without (a-d) C3 exoenzyme (20 #g/ml) for 24 h and aggregation was evoked by 0.5 (a and e), 5 (b and f), 50 (c and g), and 
500 (d and h) ng/ml of PMA.  Photographs  were taken 3 h after incubation with PMA.  Bar,  100 #m. 
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Aggregation and adhesion of lymphocytes can be evoked by 
stimuli such as T cell receptor cross-linking or phorbol ester 
treatment,  and this is due to activation of lymphocyte inte- 
grin,  LFA-1. Avidity of LFA-1 for ICAMs is increased by 
lymphocyte activation, whereas avidity of ICAMs for acti- 
vated  LFA-1  is  constitutively  high  (Dustin  and  Springer, 
1989).  The  intracellular  signal  transduction  pathway  be- 
tween the  stimuli  and  LFA-1 activation  has  remained  un- 
known. The present study used PMA-induced aggregation of 
B-lymphoblastoid JY cells as a model to elucidate possible 
involvement of the rho protein in this pathway.  Our results 
demonstrated that C3 exoenzyme preincubated with the cells 
caused in situ ADP ribosylation ofrhoA protein and inhibited 
cell aggregation induced by PMA. The two events correlated 
well in their time course and its dependency on the enzyme 
concentration.  The inhibition was abolished by prior treat- 
ment of the enzyme with the specific anti-C3 enzyme mono- 
clonal antibody,  and overcome by stimulation  with higher 
concentrations of PMA. These results suggest that the rho 
protein works as an intracellular transducer of the signal to 
integrin  activation  and  cell  aggregation.  Very  recently,  a 
similar  intermediate  role  of rhoA protein  in  a  stimulus- 
evoked cell adhesion process has been shown in the two sys- 
tems. Ridley and Hall (1992) used C3 exoenzyme, or ADP- 
ribosylated or mutant rhoA protein, and examined a role of 
rho protein in growth factor-induced stress fiber formation 
in serum-starved Swiss 3T3 cells. They found that C3 exoen- 
zyme  treatment  as  well  as  microinjection  of the  ADP- 
ribosylated rhoA protein inhibits the serum-induced forma- 
tion of stress fiber and focal adhesion, suggesting that the rho 
protein works as a link between the stimulus and adhesion. 
We (Morii et al.,  1992) examined the role of rhoA protein 
in aggregation of human blood platelets and found that ADP 
ribosylation  of platelet  rhoA  protein  inhibits  aggregation 
caused by thrombin.  This work demonstrated that the rho 
protein works downstream of the receptor-G protein coup- 
ling and phospholipase C activation in platelets. The present 
study showed that ADP ribosylation of rhoA inhibited PMA- 
induced,  protein  kinase  C-mediated  JY  cell  aggregation 
(Haverstick et al.,  1992), suggesting that the rhoA protein 
works downstream of protein kinase  C  in lymphocytes. It 
further  revealed that the C3 exoenzyme treatment did not 
affect protein phosphorylation pattern in the cells not only 
at resting but also after stimulation.  Recently, Hirata et al. 
(1992), using a skinned smooth muscle preparation,  showed 
that the C3 exoenzyme treatment abolished GTP-induced en- 
hancement of its contraction to free calcium ion, and that the 
GTP-bound form of rhoA protein restored this response. On 
the basis of the previous analysis on this "GTP-induced cal- 
cium  sensitization"  phenomenon  (Kitazawa  et al.,  1991), 
they proposed that rhoA protein exerts this action by modify- 
ing phosphorylation  of myosin light chain.  Our results on 
protein phosphorylation does not appear to support their hy- 
pothesis, and protein phosphorytation,  if significant in the 
rho protein action, would be too subtle to detect by the pres- 
ent autoradiographic  analysis. 
Then, how does the rho protein activate cell adhesion? In 
the experiments using Swiss 3T3 cells, activated rho protein 
has been shown to induce stress fiber formation and organi- 
zation of adhesion plaques (Chardin et al.,  1989; Paterson 
et al.,  1990; Ridley and Hall, 1992). They reported that the 
two events occurred in parallel,  and it is not known which 
of the two events is primarily induced by the rho protein. In 
the present study, we compared the effects of C3 exoenzyme 
and cytochalasin B on PMA-induced aggregation. As shown 
in Table I, cytochalasin B did not inhibit PMA-induced JY 
cell aggregation under the condition that it inhibited motility 
of JY cells, and inhibition of aggregation was only seen par- 
tially at the highest concentration (20 #M) of the compound. 
These results suggest that the new organization of actin fila- 
ment may not be essential to the activation of integrin and 
cell adhesion, though preexisting actin skeleton more resis- 
tant to the compound (Yahara  et al.,  1982) may have some 
role. On the other hand, inhibition of aggregation by C3 exo- 
enzyme treatment was still seen when the cell contact was 
increased by shaking. It thus clearly showed that the C3 exo- 
enzyme-induced  inhibition  of aggregation  could  be  dis- 
sociated from impairment  of cell motility by the enzyme, 
which was reported  in other systems (Stasia et al.,  1991; 
Takaishi  et al.,  1993).  Our results are consistent with the 
previous findings on blood platelets that cytochalasin B treat- 
ment inhibited pseudopodal development and organization 
of actin bundles but not platelet aggregation (Carroll et al., 
1982).  Thus,  these results taken together  suggest that C3 
exoenzyme exerts inhibition of aggregation not by affecting 
induction of actin polymerization but by affecting primarily 
the process of integrin activation. 
Then, what is the primary event in the activation of inte- 
grins? LFA-1 binding to ICAM-1 was found to be regulated 
by the cytoplasmic domain of the/3 subunit of LFA-1 (Hibbs 
et al.,  1991b) and previous studies suggested that phosphor- 
ylation of the 13 subunit may induce the high avidity state of 
the leukocyte integrin  (Chatila et al.,  1989; Buyon et al., 
1990). However, Hibbs et al. (199 la) made mutations at all 
potential phosphorylation sites of this subunit and showed 
that phosphorylation of the/3 subunit is not required for in- 
tegrin activation.  In fact, we observed that both the o~ and 
/3 subunits of LFA-1 in JY cell were constitutively phosphor- 
ylated (Tominaga, T., unpublished observation). Thus, it is 
unlikely that the/3 subunit phosphorylation is responsible for 
the integrin activation.  An alternative possibility has been 
suggested by other studies. It is known that several cytoskel- 
etal proteins such as talin,  vinculin,  and a-actinin  localize 
in close association with integrins in focal contacts (Burridge 
et al., 1988). Burn et al. (1988) and Kupfer and Singer (1989) 
showed associations of LFA-1 and talin in T lymphocytes af- 
ter the phorbol ester stimulation or the activation by antigen- 
presenting cells. In vitro association of integrins  with pro- 
teins  such  as  o~-actinin and  talin  has  also  been  shown 
(Horwitz et al.,  1986; Otey et al.,  1990). These results sug- 
gest that avidity of LFA-1 is increased by its association with 
these cytoskeletal proteins and it is likely that the rho protein 
catalyzes this association.  Further study is required to test 
this hypothesis. 
Recent studies have demonstrated that activation of inte- 
grins and resultant cell adhesion release other signals or me- 
diate some cell actions. C3 exoenzyme treatment may, there- 
fore, secondarily inhibit such processes. Lang et al. (1992) 
reported that ADP ribosylation of rhoA by C3 exoenzyme in- 
hibits natural killer cells or cytotoxic T lymphocytes-medi- 
ated cytotoxicity. Although the authors  suggested that this 
effect is due to inhibition of exocytosis, it may be secondary 
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study. 
In summary, we have shown that ADP ribosylation of rhoA 
protein by C3 exoenzyme inhibits the PMA-induced aggre- 
gation of  JY cells. This is the first report to indicate that rhoA 
protein  works  as  a  transducing  protein  in  the  stimulus- 
evoked activation of LFA-I in lymphocytes. 
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